Skip to main content
Professional Technical IVT

CERAD

Also written as: CERAD — Consortium to Establish a Registry for Alzheimer's Disease

Consortium to Establish a Registry for Alzheimer's Disease scoring system for neuritic plaques in dementia diagnosis.

Full Definition

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) provides a standardized scoring system for assessing neuritic plaque density in post-mortem brain tissue. This semi-quantitative assessment uses categories of none, sparse, moderate, or frequent plaques and is essential for neuropathological diagnosis of Alzheimer's disease. CERAD scoring is often combined with Braak staging and other criteria to establish definitive dementia diagnoses in research and clinical contexts.

Usage

Usage note: Always capitalize as acronym; spell out on first use in formal documents.

In Context

  • "The CERAD score was moderate, indicating significant neuritic plaque burden in the temporal cortex." — Autopsy report
  • "CERAD criteria should be applied consistently across all cases in the dementia research cohort." — Research protocol

Also known as

CERAD criteria CERAD scoring

Don't confuse with

Braak staging NIA-AA criteria

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON